Published
In this exclusive interview with The Capital Compass, Dr. Pete Smith from Race Oncology discusses the company's groundbreaking work on RC220, a reformulated cancer drug with a proven history of efficacy and safety.
- Category
- Oncology
Be the first to comment
Up Next
-
11:16
This Breakthrough Could Change Cancer Treatment Forever!
-
19:46
Evaluating Cancer Drug-Targeting Pathways with Large Language Models
-
05:22
HRH Princess Dina Mired joins OncoThon 2025 to Support Pediatric Cancer Research
-
14:52
Was Marriage Between Jada and Will Smith a Sham? | Jada Pinkett Smith Marriage Revelation Analysis
-
07:35
Executive Class: Vital organ screening & cancer detection at Healthway Cancer Care Hospital | ANC
-
09:25
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing
-
10:59
Roberto Vasquez Sheds Light on LMICs’ Struggles with Cancer Drug Access
-
04:26
Theranostics: A breakthrough in cancer care for Glenda
-
04:11
The Cancer Center at UM Capital Region Health provides complete cancer care for Prince George’s Coun
-
05:22
Alexandria Smith - A Young Family Copes with a Stage 4 Stomach Cancer
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
